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Abstract
Uropathogenic Escherichia coli (UPEC) strains live as commensals in the digestive tract of
the host, but they can also initiate urinary tract infections. The aim of this work was to deter-
mine how a host detects the presence of a new UPEC strain in the digestive tract. Mice
were orally challenged with UPEC strains 536 and CFT073, non-pathogenic strain K12
MG1655, and ΔPAI-536, an isogenic mutant of strain 536 lacking all 7 pathogenicity islands
whose virulence is drastically attenuated. Intestinal colonization was measured, and cyto-
kine expression was determined in various organs recovered frommice after oral challenge.
UPEC strain 536 efficiently colonized the mouse digestive tract, and prior Enterobacteria-
ceae colonization was found to impact strain 536 colonization efficiency. An innate immune
response, detected as the production of TNFα, IL-6 and IL-10 cytokines, was activated in
the ileum 48 hours after oral challenge with strain 536, and returned to baseline within 8
days, without a drop in fecal pathogen load. Although inflammation was detected in the
ileum, histology was normal at the time of cytokine peak. Comparison of cytokine secretion
48h after oral gavage with E. coli strain 536, CFT073, MG1655 or ΔPAI-536 showed that
inflammation was more pronounced with UPECs than with non-pathogenic or attenuated
strains. Pathogenicity islands also seemed to be involved in host detection, as IL-6 intestinal
secretion was increased after administration of E. coli strain 536, but not after administration
of ΔPAI-536. In conclusion, UPEC colonization of the mouse digestive tract activates acute
phase inflammatory cytokine secretion but does not trigger any pathological changes,
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illustrating the opportunistic nature of UPECs. This digestive tract colonization model will be
useful for studying the factors controlling the switch from commensalism to pathogenicity.
Introduction
Urinary tract infections (UTIs) are among the most common infections worldwide, affecting
one in two women [1]. Escherichia coli is responsible for 50–90% of all UTIs [2].
Classically, three major E. coli phenotypes are distinguished: non-pathogenic E. coli, intesti-
nal pathogenic (InPEC) and extra-intestinal pathogenic E. coli (ExPEC) [3]. Non-pathogenic
E. coli strains show no virulence ability in any animal model, and are not usually isolated out-
side of the gastrointestinal tract from sick immunocompetent patients. They also express no or
very few virulence factors. InPECs are responsible for several types of diarrhea [4], and are cur-
rently a leading cause of mortality in children worldwide [5]. ExPECs are responsible for dis-
eases outside of the digestive tract, including urinary tract infections (due to the subgroup of
uropathogenic E. coli (UPEC) strains), newborn meningitis, visceral abscesses, and septicemia
[3]. Interestingly, this observational classification has evolutionary foundations [6]. Virulence
is linked to phylogeny in E. coli species, with ExPEC predominantly belonging to phylogenetic
groups B2 and D, while commensal and InPEC are found mainly in groups A and B1.
However, the boundaries between these phenotypic groups are often tenuous. For example,
non-pathogenic phylogroup A E. coli strains have been isolated from bloodstream infections of
immunocompromised patients [7]. The Shiga toxin-producing E. coli (STEC) strain O157:H7
is a non-pathogenic commensal of cattle [8], but causes bloody diarrhea in humans (for this
reason it is considered an InPEC) [9], and has been isolated from urinary tract infections in
patients with or without uremic and hemolytic syndrome (but not frequently enough to be
classified within the ExPEC) [10, 11].
One common characteristic of all E. coli strains is that their primary habitat is the lower
digestive tract of vertebrates. It has been suspected for several decades [12, 13]–and now, well
documented [14]–that before reaching extra-intestinal sites, such as the urinary tract, ExPEC
first must integrate as part of the gut microbiota. Some individuals harbor potentially extra-
intestinal virulent E. coli strains in their digestive tract, and are therefore considered “healthy
carriers” of ExPEC [15]. These strains often belong to B2 or D phylogenetic groups, can express
many virulence factors, and are lethal when injected subcutaneously to mice [16]. Whether
and when these intrinsically virulent commensal strains are going to be responsible for an
extra-intestinal infection remains unknown, as no prospective study on extra-intestinal infec-
tion kinetics has been reported. Worldwide spread of clonal group A, which belongs to phy-
logroup D, is an illustration of this continual alternation between a commensal life in a healthy
colon and an extra-intestinal pathogenic phase; it has been isolated from the urine of women
suffering from community acquired UTI in the US [17, 18], from the blood of septicaemic
patients in Europe [19], and from the feces of healthy individuals in several locations in the US
[20]. An oro-fecal mode of transmission has even been suggested in some community UTI out-
breaks [17].
Assuming ExPEC can lead a commensal life, the determinants of the commensalism-to-
pathogenicity switch remain largely unknown. Understanding the factors (depending on the
host, the bacterium and the environment) that trigger an extra-intestinal infection in a healthy
ExPEC carrier is of importance as it could lead to new preventive strategies.
Intestinal Inflammatory Response during Colonization by Escherichia coli
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Based on these observations, it reasons that intestinal colonization is the first step of any
extra-intestinal infection. Therefore, allowing a potentially pathogenic strain to colonize the
gut is a potential threat for the host, while keeping a pathogen-free intestine ensures subse-
quent health.
The main goal of this work was to determine how the establishment of a UPEC strain as a
commensal in the digestive tract was detected by the host, and whether the detection was in
relation to virulence status of the incoming strain. To address these questions, we developed a
new mouse model to study digestive tract colonization by E. coli. This model did not involve
antibiotic treatment and thereby avoided disruption of the resident microbiota, as antibiotic-
induced alterations in the gut microbiota influence host immunity [21, 22].
Material and Methods
Bacterial strains
Uropathogenic E. coli strain 536 was isolated from the urine of a German patient suffering
from acute pyelonephritis [23]. It belongs to the B2 phylogenetic group, sub-group III, STc127
[24], and harbors an O6 serogroup [25]. Its genome has been completely sequenced [26]. This
strain is naturally resistant to streptomycin.
ΔPAI-536 is an isogenic mutant of E. coli strain 536 in which all 7 pathogenicity islands
have been deleted [27]. The virulence of this mutant is drastically decreased [28].
Strain K-12 MG1655 is a laboratory-derived commensal E. coli strain. It belongs to the A
phylogenetic group, harbors serogroup O16 and has no antibiotic resistance or virulence fac-
tors. Strain CFT073 is a uropathogenic E. coli strain [29], that belongs to the B2 phylogenetic
group, sub-group II, STc73 and harbors serogroup O6.
Ethics statement
All animal experiments were performed in strict accordance with the guidelines of the Univer-
sity of British Columbia Animal Care Committee and the Canadian Council on the Use of Lab-
oratory Animals. The protocol was approved by the UBC Animal Care Committee (Certificate
number: A09-0168). Mice were monitored once daily by the experimenter and once daily by
the animal facility staff throughout the experiment. An early endpoint (weight loss>15%) was
used to euthanize severely ill animals prior to the experimental endpoint. No animal died prior
to the experimental endpoint, and no animal ever reached the early endpoint. The mice were
euthanized by CO2 asphyxiation and all efforts were made to minimize suffering.
Mice
All experiments were performed on 6-week old C3H/HeOuJ or C57BL/6J mice (Jackson Labo-
ratory, Bar Harbor, ME, specific and opportunistic pathogen free upon arrival), housed in the
specific pathogen-free animal facility at the University of British Columbia (UBC). Mice were
fed standard chow (Laboratory Rodent Diet 5001, Purina Mills, St. Louis, Missouri) ad libitum
throughout experiments, and had free access to sterile water. Prior to any treatment, one
fecal pellet (minimum weight: 20 mg) was collected from each mouse. Fecal samples were
resuspended in 1 mL of sterile phosphate-buffered saline (PBS) with a MM 301 mixer mill
(Retsch, Newtown, PA), for 3 min at 25 Hz, and 100 μL of the fecal suspension were plated on
MacConkey and on MacConkey+streptomycin (30 μg/mL) agar plates. The limit of detection
was 500 CFU/g of feces, i.e. 2,7 log10 (CFU/g feces). All C57BL6/J mice were free of Enterobac-
teriaceae (no growth on MacConkey agar upon arrival and until the day mice were used
for oral gavage). In contrast upon arrival, some cages harbored C3H/HeOuJ mice who all
Intestinal Inflammatory Response during Colonization by Escherichia coli
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contained Enterobacteriaceae, while other cages harbored only Enterobacteriaceae-free C3H/
HeOuJ mice. However, no C3H/HeOuJ mice contained streptomycin-resistant Enterobacteria-
ceae upon arrival in the mouse facility and until mice were used for oral gavage.
E. coli oral challenge
A single colony of E. coli strains 536, ΔPAI-536, MG1655 or CFT073 was inoculated in 5 ml
of lysogeny broth at 37°C, overnight under constant shaking (200 rpm). The following day, 1
mL of culture was spun down (6 min at 6000 x g), and washed twice in PBS. Mice received
oral gavage with a 100 μL suspension containing 107 colony forming units (CFU). For each
experiment, the inoculum was checked by plating serial dilutions on MacConkey agar plates.
E. coli strain 536 was indifferently administered to mice colonized with or free of Enterobac-
teriaceae, whereas Enterobacteriaceae-free mice only were used to administer ΔPAI-536,
MG1655 or CFT073. Fecal pellets were collected every day or every other day after mice were
individually placed in isopropanol-washed plastic jars. After weighing, a small fecal sample
was resuspended in 1 mL of PBS. Ten-fold serial dilutions were plated on MacConkey
(MG1655 or CFT073) or on MacConkey+streptomycin 30 μg/mL (E. coli strain 536 and
ΔPAI-536) agar plates. Each experiment was repeated at least twice, with at least 4 mice in
each tested condition.
Organ supernatant preparation
Mice were euthanized by cervical dislocation following CO2 asphyxiation at the desired time
point. Bladders, kidneys, spleens, livers, and mesenteric lymph nodes were collected in 250 μL–
1000 μL of PBS + 2X Complete1 EDTA-free proteinase inhibitor (Roche™, 1 tablet for 25 mL
of PBS). Segments of ileum, caecum and colon were collected in 1 mL of PBS + 2X Complete1
EDTA-free proteinase inhibitor + 0.01% soybean trypsin inhibitor (Sigma). Upon collection,
all samples were kept at 4°C throughout sample processing, and subsequently frozen at -80°C.
All organs were collected in 2 mL safe-lock1 tubes containing one autoclaved 5 mm tungsten
bead. Samples were resuspended by shaking (mixer-mill, 3 min, 25 Hz), and centrifuged (5
min 14,000 g). Supernatants were transferred to fresh tubes and frozen at -80°C.
Simultaneous multiple cytokine measurements in organ supernatants
Monocyte Chemotactic Protein 1 (MCP-1), Interleukin (IL) 1β, IL-4, IL-5, IL-6, IL-10, IL-12,
IL-13, IL-17, IL-21, Interferon (IFN) γ, and Tumor Necrosis Factor (TNF) α were simoulta-
neously measured in multiple samples using BD bioscience™ Cytometric Bead Array (CBA flex
set multiplex) according to manufacturer’s instructions. Organ supernatants were thawed at
4°C, and 50 μL were used for the cytokine screen. Cytokine concentrations were normalized by
the sample weight.
ELISA
Organ supernatants were thawed at 4°C, and 100 μL were used for IL-6, IL-10, and TNF-α
enzyme-linked immunosorbent assays (ELISAs) (OptEIA1, BD biosciences™) according to
manufacturer’s instructions. Cytokine concentrations were normalized by the sample weight.
Histopathology
Ileum samples were fixed in 10% neutral buffered formalin overnight and then placed in 75%
ethanol. Fixed tissues were embedded in paraffin and cut into 5 μm sections. Tissues were
Intestinal Inflammatory Response during Colonization by Escherichia coli
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stained with haematoxylin and eosin, using standard techniques by Wax-it Histology Services
(Vancouver, BC, Canada).
Statistical analyses
Series of homoscedastic data (Brown-Forsythe’s and Barlett’s tests) with a normal distribution
(Kolmogorov-Smirnov test) are expressed as means ± standard deviation and compared by t-
tests or one-way ANOVA with Bonferroni’s correction for multiple comparisons, as appropri-
ate. Series of non-Gaussian data are represented as median and interquartile range or box and
whiskers (median, interquartile range and minimum-maximum values), and compared by
Mann-Whitney U test or Kruskal-Wallis test with Dunn’s correction for multiple comparisons,
as appropriate. The proportion of mice who cleared E. coli were compared by Χ² test. The test
that was used is specified in the result section and in the legend of each figure.
All statistics were performed using Prism1 6.05 (GraphPad Software Inc).
Results
UPEC strain 536 efficiently colonizes the mouse digestive tract
An inoculum of 107 CFU of E. coli strain 536 was orally administered to C3H/HeOuJ mice and
intestinal colonization was assessed by plating fecal samples on MacConkey+streptomycin
(30 μg/mL) agar plates daily or every second day for 8 days. E. coli strain 536 is naturally resis-
tant to streptomycin, facilitating selection. Mice were free of streptomycin resistant Enterobac-
teriaceae upon arrival in the animal facility (see Material and Methods). Additionally, 50 fecal
clones were randomly selected on MacConkey plates and tested for E. coli phylogenetic group
and B2 sub-group by quadriplex and specific PCR, respectively [30, 31]. Only B2 sub-group III
clones were isolated, which corresponds to E. coli strain 536 group and sub-group.
After a single oral challenge, inter-individual digestive tract colonization was variable but
high, ranging from 5.0 to 9.9 log10 (CFU/g of feces) (Fig 1A). The mean bacterial count was 6.9
±1.1 log10 (CFU/g of feces) and remained greater than 5.9 log10 (CFU/g of feces) throughout
the experiment. The mean fecal concentration of E. coli was not statistically different from day
1 through day 8 after oral challenge (p = 0.1 by one-way ANOVA), indicating stable coloniza-
tion on the short term. Interestingly, each mouse maintained their initial (day 1) level of E. coli
throughout the experiment (until day 8), i.e. mice with the highest/lowest E. coli fecal burden
kept a high/low burden throughout the experiment. Colonization of caecum and ileum paral-
leled fecal concentrations (data not shown).
Colonized mice showed no overt sign of disease. They did not suffer from diarrhea, and
their weight remained stable throughout the experiment (data not shown).
In order to ensure that E. coli strain 536 colonization capacity was not restricted to C3H/
HeOuJ mice, the same inoculum was orally administered to C57BL6/J mice. Similar coloniza-
tion properties were observed (Fig 1B). Mean fecal concentration in C57BL6/J mice did not sig-
nificantly decrease during the first four days after oral gavage (p = 0.15 by one-way ANOVA).
As the purpose of this work was to study the very initial phase of intestinal colonization, fecal
bacterial concentration in C57BL6/J mice was not assessed after day 4.
Pre-colonization with Enterobacteriaceae drastically affects subsequent
E. coli strain 536 intestinal colonization
Upon arrival at the animal facility, a fecal sample was taken from each mouse and plated on
MacConkey agar. Some C3H/HeOuJ mice showed intestinal colonization with Enterobacteria-
ceae (possibly non-pneumoniae Klebsiella, as indicated by the provider). Others were free of
Intestinal Inflammatory Response during Colonization by Escherichia coli
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Enterobacteriaceae based on plating on MacConkey agar. However, no mice showed intestinal
colonization with streptomycin-resistant Enterobacteriaceae as indicated by the absence of
bacterial growth on MacConkey+streptomycin agar plates. Fig 1C shows pooled E. coli fecal
counts from day 1 to day 8 post gavage as a function of Enterobacteriaceae pre-colonization.
Enterobacteriaceae-colonized mice showed significantly lower colonization over 8 days after a
single oral challenge than Enterobacteriaceae-free mice. Median fecal bacterial count of Entero-
bacteriaceae-free mice was 6.3 log10 (CFU/g of feces) while median fecal bacterial count of
Enterobacteriaceae-colonized mice was 5.7 log10 (CFU/g of feces)(p<0.01 by t-test). This indi-
cates that intestinal colonization by an incoming strain can be affected by resident phylogeneti-
cally related bacteria.
E. coli strain 536 establishment in the mouse digestive tract triggers an
innate immunity response in the ileum
To determine whether intestinal colonization of a UPEC strain was detected by the host
through inflammation, we measured cytokine production. We used a cytometric bead assay
screen to simultaneously measure expression of 13 cytokines in 7 organs of 3 groups of 4 mice.
The measured cytokines were: MCP-1, IL-1β, IL-12, IL-6, TNFα (in order to explore acute
phase and innate immunity), IFNγ, (and again TNFα, Th1 inflammatory response), IL-4, IL-5,
IL-6, IL-13 (Th2 inflammatory response), IL-17, IL-21 (Th17 inflammatory response) and IL-
10 (Treg activation). These cytokines were measured in homogenates of bladder, spleen, kid-
ney, mesenteric lymph nodes, ileum, caecum, and distal colon. Cytokines were measured in
mice sacrificed 2 or 8 days after an oral challenge with E. coli strain 536 or PBS (controls). This
screen showed elevated levels of IL-6, TNFα and IL-10 secretion in the ileum 2 days after oral
challenge, but not of the other cytokines (data not shown). In order to confirm this result, spe-
cific ELISAs were performed on supernatants of ileum, colon or caecum homogenates (Fig 2).
Control mice were sacrificed 2 days after PBS oral gavage, while test mice were sacrificed either
2 or 8 days after a single oral challenge with 107 CFU E. coli strain 536. At day 2, median
TNFα, IL-6, and IL-10 concentrations increased 2.9, 5.0, and 3.8 fold respectively, in the ileum
of E. coli-challenged mice compared to control mice. By day 8 post-infection, cytokine secre-
tion in the ileum returned to a level that was not statistically different from control mice
Fig 1. Intestinal colonization after a single oral challenge with 107 CFU of UPEC strain 536. Fecal pellets were individually collected from C3H/HeOuJ
(A) or C57BL6/J (B) mice every day or every other day after oral challenge. E. coli strain 536 CFUs were enumerated in the feces by serial dilution on
MacConkey+streptomycin (30 μg/mL) agar plates and expressed as log10 (CFU/g feces). Mean bacterial loads were not significantly different over time (Fig
1A and 1B, one-way ANOVA with Bonferroni’s correction for multiple comparisons). C: Some C3H/HeOuJ mice provided by Jackson Laboratory were
colonized by Enterobacteriaceae and others were not. Here, fecal counts on days 1 to 8, from Fig 1A are pooled, and represented according to the presence
or absence of Enterobacteriaceae prior to oral gavage with E. coli strain 536. The line indicates a significant difference with p<0.01 (t-test). Bars and whiskers
represent means ± standard deviation (Fig 1A and B) or median and interquartile range (Fig 1C).
doi:10.1371/journal.pone.0153034.g001
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(Fig 2A). In contrast, TNFα, IL-6 and IL-10 secretion was indistinguishable between orally-
challenged and control animals at day 2 in the caecum and the distal colon (Fig 2B and 2C).
The cytokine secretion profile and timing is consistent with an acute phase inflammatory
response in the ileum. Because no inflammatory response was found in any other portion of
the intestine, the ileum may be the specific site of recognition of this potentially harmful extra-
intestinal pathogen after oral ingestion.
E. coli strain 536 does not induce enteritis after oral challenge
Because acute phase cytokines were detected in the ileum 2 days after oral challenge with E. coli
strain 536, histologic analysis was performed to look for enteritis. Hematoxylin and eosin stains
were performed on ileum sections of mice sacrificed 2 days after oral challenge. These sections
showed no sign of inflammation (Fig 3). There was no detectable degree of mucosal edema or
hemorrhage, leucocyte infiltrate, intestinal epithelial cell necrosis, or epithelial cell debris
Fig 2. TNFα, IL-6, and IL-10 cytokine ELISAmeasurements in the ileum (A), caecum (B) and colon (C) 2 days after oral gavage with 100 μL of PBS
(controls), and 2 or 8 days after oral gavage with 107 CFU of E. coli strain 536. Box and whiskers represent medians and interquartile ranges. Lines
indicate significant differences with p<0.01 (Mann-Whitney U test).
doi:10.1371/journal.pone.0153034.g002
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shedding in the lumen. Crypt organization was always conserved. All the sections were optically
normal.
This indicates that even though E. coli strain 536 elicits the production of inflammatory
cytokines in the ileum, this inflammation remains subclinical. Thus E. coli strain 536 is an
extra-intestinal pathogen that is not capable of inducing clinical enteritis in this model.
UPEC strains 536 and CFT073 induce a more pronounced ileal innate
immunity response than non-pathogenic E. coli strains MG1655 and
ΔPAI-536
E. coli strain 536 is recognized as a highly virulent strain in the E. coli species. Deletion of all 7
pathogenicity islands (PAIs) is required to dramatically reduce its virulence [28]. In order to
assess whether the ileal innate immune response observed after 536 oral administration was in
relation with its intrinsic virulence, ileal cytokine concentrations were compared after oral
gavage of C3H/HeOuJ mice with strain ΔPAI-536, which is an isogenic mutant of E. coli strain
536 in which all 7 PAIs have been deleted[27], and whose pathogenicity is drastically attenu-
ated, non-pathogenic strain MG1655, and two UPEC strains (CFT073 and E. coli strain 536).
Two days after oral challenge, IL-6 concentrations were increased in mice challenged with 536
(positive control) and CFT073 compared to the mice that received PBS (Fig 4A; Kruskal-Wallis
test with Dunn’s correction for multiple comparisons, p = 0.005). In addition, IL-10 and TNFα
concentrations were higher after oral gavage with CFT073 than after oral gavage with PBS
(Kruskal-Wallis test with Dunn’s correction, p = 0.009 and p = 0.01, respectively). To complete
the analysis, the same cytokine concentration measurements were pooled in 3 groups: PBS,
non-pathogenic or attenuated strains (MG1655 and ΔPAI-536) and UPECs (E. coli strain 536
and CFT073). Overall, at day 2, the innate immunity response was higher after oral challenge
with UPEC than with non-pathogenic or attenuated strains (p ranging between 0.002 and 0.06
for all the comparisons, Fig 4B). Mice who received non-pathogenic or attenuated E. coli strains
tended to have a higher IL-10 ileal production than control mice.
Interestingly, while all mice showed a high intestinal colonization as measured by E. coli
fecal concentration at day 1 after oral gavage (Fig 4C, no difference between groups of mice), a
Fig 3. A, and B: Hematoxylin and eosin stain of an ileum section of a mouse 2 days after oral challenge with 107 CFU of E. coli strain 536. A: 10X
magnification. B: 40X magnification.
doi:10.1371/journal.pone.0153034.g003
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few mice challenged with ΔPAI-536 and most mice challenged with MG1655 had cleared the
E. coli strain at the time of sacrifice for cytokine measurement (day 2). At day 2, when mice
who showed no E. coli in their feces were assigned an arbitrary E. coli concentration of 102.7
CFU/g of feces (which corresponded to the limit of detection of our method), the colonization
of mice was lower with MG1655 than with E. coli 536 (p = 0.02, Kruskal-Wallis test with
Dunn’s correction for multiple comparisons). The proportion of mice who cleared E. coli was
Fig 4. A: TNFα, IL-6, and IL-10 cytokine ELISAmeasurements in the ileum 2 days after oral gavage with 100 μL of PBS (controls), or 107 CFU of ΔPAI-536,
MG1655, CFT073 or E. coli strain 536. Box and whiskers represent medians and interquartile ranges. Lines indicate significant differences (p<0.05 by
Kruskal-Wallis test with Dunn’s correction for multiple comparisons). B: the same measurements are represented in 3 groups: PBS (controls), non-
pathogenic or attenuated strains (pooled data from ΔPAI-536 and MG1655) and UPEC strains (pooled data from CFT073 and E. coli strain 536). Box and
whiskers represent medians and interquartile ranges. Lines indicate significant differences (Mann-Whitney U tests). C: E. coli fecal concentration one and
two days (time of the sacrifice for cytokine measurement) after oral gavage. Bars and whiskers represent medians and interquartile ranges. Mice who cleared
E. coli were assigned a bacterial load of 500 CFU g/feces, i.e. 2.7 log10 (CFU/g of feces), which was the limit of detection in our model. The line indicates a
significant difference (Kruskal-Wallis tests with Dunn’s correction for multiple comparisons). Enterobacteriaceae-free C3H/HeOuJ mice only were used for
this experiment. E. coli CFUs were enumerated in the feces by serial dilution on MacConkey agar plates and expressed as log10 (CFU/g feces). Each dot
represents one E. coli fecal count.
doi:10.1371/journal.pone.0153034.g004
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also higher after oral gavage with MG1655 or Δ-PAI536 than after oral gavage with E. coli
strain 536 or CFT073 (p<10−6 for the global comparison, and p<10−3 for comparisons 2 by 2
by Χ² tests). However, no correlation between E. coli fecal concentrations and cytokine levels
were found.
Discussion
The aim of this work was to study the integration of a UPEC strain into the digestive tract of a
murine host as it models the first step in an extra-intestinal infection. We also wanted to assess
whether host detection was modified by the virulent status of the strain.
Most of the previously published models of E. coli intestinal colonization include antibiotic
pretreatment [27, 32, 33]. However, we have shown that it is possible to colonize mice effi-
ciently with various E. coli strains without the use of antibiotics, at least in the short term. Anti-
biotics are often useful to increase colonization yield or to reinforce virulence of intestinal
pathogens [32], but are not necessary when colonization is the goal. Indeed, in streptomycin-
treated mice orally inoculated with E. coli strain 536, its fecal concentration was between 109
and 1010 CFU/g of feces [27], a non-physiological level for commensal E. coli [15]. Avoiding
the use of antibiotics is of value in studying pathogen colonization as antibiotic pretreatment
modifies host gut microbiota [34], therefore impacting any subsequent analysis of pathogen-
microbiota specific interactions. Furthermore, antibiotic-induced alterations of microbiota
drastically affect host immunity [21, 22, 35], another limiting step in many pathogen-host
interaction studies. An alternative method has been recently proposed where pregnant female
rats were treated with streptomycin and inoculated with streptomycin-resistant E. coli. The
commensal E. coli strains are transmitted to the offspring and persistently colonized the gut
at a level of 106 CFU/g of feces after weaning without any antibiotic [36]. The model that we
describe here is simpler, and could be used to study the gut as a reservoir of ExPEC.
E. coli strain 536 is a known human extra-intestinal pathogen [23] and its high intrinsic viru-
lence has been established in various animal models [26, 28], as well as by the description of its
many virulence factors [26]. We have shown that E. coli strain 536 elicited a transient innate
immunity response in the ileum 48 hours after oral administration. However, intestinal histology
of colonized mice at 48 hours post oral challenge was normal, and E. coli 536 fecal colonization
did not drop. In addition, we have shown that CFT073, another UPEC strain, also elicited a tran-
sient innate immunity response in the ileum. To the contrary, non-pathogenic strain MG1655
and an isogenic mutant of 536 which lacked all 7 PAIs elicited a lower inflammatory response
than what was triggered by UPEC strains. Only ileal IL-10 production tended to be higher in
mice who received a non-pathogenic or attenuated E. coli strain than in control mice. Of impor-
tance, IL-6 ileal synthesis was not significantly higher after oral administration of ΔPAI-536 than
after gavage with PBS, while in contrast it was higher after oral gavage with E. coli 536 than in
control mice. This is a direct demonstration that virulence factors condition the host’s response.
The 7 PAIs of E. coli strain 536 [26] and the 9 PAIs of CFT073 [37, 38] contain many viru-
lence factors, some of which could constitute “Pathogen Associated Molecular Patterns”
(MAMPs) and be recognized by the innate immunity machinery. For example, capsule anti-
gens (kpsK15 harbored on PAI V536 [39] or kpsK12 harbored on PAI ICFT073 [38]) or Antigen 43
[40] (PAI III536 [26] and PAI ICFT073 [38]) are hypothetical candidates for this role. Further-
more, we showed that non-pathogenic strains Δ-PAI536 and MG1655 were inefficient coloni-
zators of the digestive tract compared to ExPEC strains 536 and CFT073. Again, some
virulence factors contained on PAIs could contribute to this observation. In particular, adhe-
sion molecules such as fimbriae of type P (PAI II536 [26], PAI ICFT073 [41], and PAI IICFT073
[42]), S (PAI III536 [26]), F17 (PAI I536 [39]), F1C (PAI-SerXCFT073 [38]) and CS12 (PAI I536
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[39]) could be involved. Consistently, it has been demonstrated that wild-type E. coli strain 536
was able to outcompete ΔPAI-536 in the streptomycin mouse model of intestinal colonization
[27]. Being an ExPEC, i.e. belonging to the B2 phylogroup and possessing numerous virulence
factors, may allow better intestinal colonization, based on epidemiological [43, 44], and experi-
mental [27, 45–47] data. This implies that depending on the environment, the same molecule
could act as a fitness element (for example when colonizing the digestive tract) or a virulence
factor (for example, when colonizing the urinary tract [37]). Pathogenicity appears to be a by-
product of commensalism[48].
Our work is an illustration of the physiological role of inflammation in detecting and con-
trolling an incoming potential pathogen. There is abundant literature about the deleterious
effects of inflammation in the context of disease. Inflammation leads to fibrotic scars, which
can interfere with normal functioning of the affected organ. In extreme cases, excessive inflam-
mation can lead to host death, such as the cytokine storm which occurs in septic shock [49].
This is also the reason why there is a danger in over responding to a pathogen [50]. Conversely,
what was observed was likely the response of a normally functioning host. While the host
seems to be “blind” to many gut bacteria [51] (here MG1655 and ΔPAI-536 merely triggers
cytokine secretion), UPEC strains 536 and CFT073 represent a threat and are therefore
detected as such in the ileum. However, activation of innate immunity did not result in a
decrease of strain 536 fecal abundance nor result in any visible disease in the host. This obser-
vation is an experimental demonstration of the opportunistic nature of ExPEC. Whether the
healthy carrier mice have an increased risk for subsequent extra-intestinal infection is not
known. This key question is difficult to explore as no model of spontaneous extra-intestinal
infection with a high incidence currently exists. Similarly, in human medicine prospective stud-
ies on urinary tract infections are lacking. The exact kinetics between the intestinal acquisition
of a UPEC strain and the development of a UTI, as well as the triggering factors are unknown.
Conclusion
Extra-intestinal virulence appears to be an extremely complex phenomenon, and is the result
of a network of interactions. Most of the scientific effort has been focused on the sequence of
gene activations controlled by the host and/or the pathogen during the infectious processes.
Upstream phenomena, such as host colonization by potential pathogens should also be
explored as this could open the door to new preventive strategies.
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